ArticleDer Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen2021
[The "hot" thyroid gland carcinoma and a critical look at thermal ablation].
Article in Der Chirurg; Zeitschrift fur alle Gebiete der operativen Medizen, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed, 0 citations in OpenAlex.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hot and hyperfunctioning thyroid gland nodules are currently treated primarily by radioiodine or surgical resection. In recent years local thermal ablation as an alternative therapeutic modality is increasingly recommended. This article reports the case of a patient with a hot thyroid nodule, which was resected and turned out to be follicular thyroid cancer. In this context it appears to be necessary to critically question thermal ablation as an alternative treatment option for thyroid nodules, particularly since the current recommendations are weak with low or even very low evidence. Radioiodine or surgery remains the first-line treatment for hot and hyperfunctioning thyroid nodules but malignancy in a hot thyroid nodule also needs to be considered.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.